Awm Investment Company, Inc. Axogen, Inc. Transaction History

Awm Investment Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $3.25 Million - $4.92 Million	-222,500 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$17.09 - $38.25 $236,662 - $529,686	-13,848 Reduced 5.86%	222,500 $4.55 Million
Q3 2018 Nov 09, 2018	SELL	$34.05 - $55.9 $856,629 - $1.41 Million	-25,158 Reduced 9.62%	236,348 $8.71 Million
Q1 2018 May 10, 2018	SELL	$24.4 - $40.25 $488,000 - $805,000	-20,000 Reduced 7.1%	261,506 $9.55 Million
Q4 2017 Feb 13, 2018	SELL	$18.5 - $28.6 $1.03 Million - $1.59 Million	-55,500 Reduced 16.47%	281,506 $7.97 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $4.94 Million - $6.52 Million	337,006	337,006 $6.52 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $534M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.